In this issue:
- Role of ultra-high-frequency ultrasound in BCC diagnosis and management
- Chronic immune-related adverse events after adjuvant anti-PD1 for high-risk resected melanoma
- Real-life management of incompletely excised BCC
- Adjuvant treatment and outcomes of stage III melanoma
- Electrodesiccation and curettage for SCC in situ: effect of anatomical location on recurrence
- Ipilimumab ± nivolumab in anti-PD-(L)1-refractory metastatic melanoma
- Narrow vs. wide excision for T1 radial growth phase melanoma
- ctDNA-based residual disease detection for monitoring advanced melanoma treatment
- Incisional antibiotics for preventing surgical-site infections in skin cancer surgery
- Nivolumab + relatlimab in progressive advanced melanoma after anti-PD-(L)1
Please login below to download this issue (PDF)